The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Survival Experience in The Breast Cancer Detection Demonstration Project
Open accessAbstract
Very high survival rates have been observed in four through 11 years of follow-up in 4,240 women with a histologically confirmed diagnosis of breast cancer in the Breast Cancer Detection Demonstration Project (BCDDP). The relative five, eight, and 10-year survival rates were 88, 83, and 79 percent, respectively. Allowances were made for lead-time bias among cancers detected through screening, and the validity of the findings was supported by internal analyses, which showed that length-time bias was of little, if any, importance, and that any possible "overdiagnosis" of cancer cases was also of small relevance. In view of current interest in the value of screening women before age 50, intensive analyses were made comparing the BCDDP data for women in their 40s with women in their 50s. In terms of kinds of breast cancers found, modality of finding them, and survival rates once they have been found, the parallel results for the two groups show that screening was virtually as effective in the younger as in the older women. Some authorities are of the opinion that the benefits of mammography after age 50 are well documented, but at younger ages the evidence is still inconclusive. The findings in this study show there is no doubt of the very successful results of screening for breast cancer with mammography in younger as well as older women. In comparing relative five-year and eight-year survival rates for women with invasive breast cancers detected through screening in the BCDDP, with those for cases diagnosed in the National Cancer Institute's Surveillance, Epidemiology and End Results (NCI SEER) program from 1977 to 1982, it is seen that for individual subcategories by tumor size and nodal class, the survival rates are about the same. However, for overall invasive cancers, the five-year and eight-year survival rates were 87 and 81 percent, respectively, for the BCDDP compared with 74 and 65 percent for SEER. Thus the substantial gains in survival followed the large shift toward a high proportion of cancers being diagnosed and treated in more favorable stages through the screening accomplishments. With respect to the relative case fatality rates, the complements of the relative survival rates, the eight-year rate of 19 percent for the BCDDP versus that of 35 percent for SEER connotes 46 percent fewer women dying in the BCDDP group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Peto, R. (1983) · The Use of Human Cells for the Evaluation of Risk from Physical and Chemical Agents · doi:10.1007/978-1-4757-1117-2_30 · Cited by 3,501
REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY
Tabár, L., Gad, A., Holmberg, L. H., Ljungquist, U., Fagerberg, C. J. G., Baldetorp, L., Gröntoft, O., Lundström, B., Månson, J. C., Eklund, G., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92204-4 · Cited by 1,781
Ten- to Fourteen-Year Effect of Screening on Breast Cancer Mortality 2
(1982) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/69.2.349 · Cited by 840
Breast Cancer Detection Demonstration Project: Five-Year Summary Report
Baker, L. H. (1982) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.32.4.194 · Cited by 694
REDUCTION OF BREAST CANCER MORTALITY THROUGH MASS SCREENING WITH MODERN MAMMOGRAPHY
Verbeek, A. L. M., Holland, R., Sturmans, F., Hendriks, J. H. C. L., Avunac, M., & Day, N. E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91703-3 · Cited by 495
Bailar, J. C., & Smith, E. M. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605083141905 · Cited by 409
LEAD TIME IN BREAST CANCER DETECTION AND IMPLICATIONS FOR PERIODICITY OF SCREENING1
Shapiro, S., Goldberg, J. D., & Hutchison, G. B. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112046 · Cited by 137
UICC project on screening for cancer: Report of the workshop on screening for breast cancer
Day, N. E., Baines, C. J., Chamberlain, J., Hakama, M., Miller, A. B., & Prorok, P. C. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910380302 · Cited by 65
An analysis of survival differences between clinically and screen‐detected cancer patients
Habbema, J. D. F., van Oortmarssen, G. J., & van Putten, D. J. (1983) · Statistics in Medicine · doi:10.1002/sim.4780020224 · Cited by 35
Cited by
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
Smith, R. A., Saslow, D., Andrews Sawyer, K., Burke, W., Costanza, M. E., Evans, W. P., Foster, R. S., Hendrick, E., Eyre, H. J., & Sener, S. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.3.141 · Cited by 770
Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography
Ernster, V. L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1546 · Cited by 582
Physicians' recommendations for mammography: do tailored messages make a difference?
Skinner, C. S., Strecher, V. J., & Hospers, H. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.1.43 · Cited by 506
Barton, M. B., Harris, R., & Fletcher, S. W. (1999) · JAMA · doi:10.1001/jama.282.13.1270 · Cited by 375
Eddy, D. M. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440030128037 · Cited by 261
Metadata
- Authors
- Seidman, H., Gelb, S. K., Silverberg, E., LaVerda, N., & Lubera, J. A.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 1987-09-01
- Volume
- 37
- Issue
- 5
- Pages
- 258-290
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2003167490
- Cited by
- 306
- References
- 9
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Survival Experience in The Breast Cancer Detection Demonstration Project. https://app.cochat.ai/papers/10.3322/canjclin.37.5.258
- The paper
- Seidman, H., Gelb, S. K., Silverberg, E., LaVerda, N., & Lubera, J. A. (1987). Survival Experience in The Breast Cancer Detection Demonstration Project. CA: A Cancer Journal for Clinicians. https://doi.org/10.3322/canjclin.37.5.258
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.